Pharmacy

1712 Carey Ave. Ste 200 Cheyenne, WY 82002
Phone: 307-634-9636 Fax: 307-634-6335 bop@wyo.gov

Mission Statement

The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.

License Verification

Prescription Drug Monitoring Program

Current News & Information

WYOMING STATE BOARD OF PHARMACY

Board Meeting Agenda

March 26, 2025 11:00 am

200 W 24th St, Cheyenne, WY 82001

(State Capitol Extension – Public Meeting Room 5)

Participants may join the meeting virtually with the following Google Meeting ID:

https://meet.google.com/pjs-izqn-ewe or by calling: 1 361-360-8326 PIN: 521 762 214#

Persons requiring special assistance to be able to attend and/or participate in the Board’s meeting are asked to contact the Board office at 307-634-9636 in advance of the meeting to ensure that arrangements and accommodations are made. While the Board attempts to follow the agenda as published, it reserves the right to vary from the times and order of matters below as may be appropriate and necessary to facilitate the flow of business.

Wyoming Pharmacy Act Rules Chapter 8: Wholesale Distributor Regulations – Emergency Rule Revisions

The Wyoming State Board of Pharmacy has proposed Emergency Rules for the Wyoming Pharmacy Act Rules, Chapter 8 Wholesale Distributor Regulations. On June 10, 2021, the U.S. Food and Drug Administration (FDA) finalized Guidance for Industry #263 (GFI 263), which outlines the process for animal drug sponsors (the entity responsible for developing and selling animal drugs) to voluntarily change the approved marketing status of medically important veterinarian drugs from over-the-counter (OTC) to prescription (Rx). GFI 263 went into effect in June 2023.

This change made these drugs only useable under the supervision of a licensed veterinarian pursuant to a prescription. Other states enacted state specific legislation and/or rules in response to GFI 263. Wyo. Stat. § 33-24-153 requires the Board of Pharmacy to issue an order to cease distribution to a drug distributor if the distributor has sold, distributed or transferred a prescription drug to a person who is not authorized to receive the prescription drug under the law of the jurisdiction in which the person receives the prescription drug.

Because of GFI 263, other states regulations, and the language in Wyo. Stat. § 33-24-153, wholesale distributors of veterinary medications have recently begun to refuse to sell or deliver veterinary prescription drugs to Wyoming ranchers and livestock owners. On January 6, 2025, Board of Pharmacy staff were notified of this situation and the need for immediate action by the Wyoming Livestock Board.

The emergency rule clarifies that veterinary prescription drug wholesalers may sell or deliver non-controlled substance veterinary medications to a person responsible for the control of a livestock animal, as defined in Wyo. Stat. § 11-29-101(a)(vi) subject to specified conditions. The emergency rule was approved by Governor Gordon on January 29, 2025.

2025 Renewals for Pharmacists and Pharmacy Technicians are now Late

An active license is required to practice in Wyoming. Pharmacist and pharmacy technician renewals are now subject to an additional late fee. For 2025 license renewals:

Pharmacists must complete 15 hours of ACPE-accredited continuing education, including 1.5 hours related to responsible prescribing of controlled substances. Any CE activity that is coded to ACPE topic “8” will meet this requirement.
Pharmacy technicians must complete 10 hours of ACPE-accredited continuing education.
Pharmacists and pharmacy technicians who immunize must complete 1 hour of CE related to immunizations.
ALL CE must be ACPE-accredited and be reported to NABP's CPE Monitor.
Certification or recertification of CPR, ACLS, or PALS by the American Red Cross or the American Heart Association is no longer recognized as acceptable CE unless the course is ACPE-accredited.

As a reminder, separate immunization and/or preceptor registrations are no longer required.

For more information on CE requirements, please refer to the Wyoming Pharmacy Rules Chapter 6 Continuing Professional Education Regulations.

Alerts & Other Information

A Reminder that PREP Act Declaration for COVID-19 Countermeasures were extended through December 2024

PREP Act immunity from liability was extended by HHS through through the final day of the applicable Declaration of Emergency, or December 2024 to pharmacists, pharmacy interns, and pharmacy technicians to administer COVID-19 and seasonal influenza vaccines (to those individuals three and over, consistent with other requirements), and COVID-19 tests, regardless of any USG agreement or emergency declaration. For additional information:

REMINDER ALERT

Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert

The Board's September 2022 newsletter had an article on the Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition's fraud alert that outlines some new methodologies that are being used to divert both small and large drug shipments. These schemes may involve the impersonation of regulatory personnel, including individuals from state boards of pharmacy and departments of health. They may also involve the impersonation of pharmacy or distributor staff.

Last week a pharmacy in Casper reported being contacted by a scammer posing as the Wyoming Board of Pharmacy, who tried to obtain their wholesale distributor account number. In 2022, a pharmacy in Rock Springs, WY, reported being contacted by a scammer posing as their distributor, who said that they had shipped product to the pharmacy in error and requested that the shipment be returned.

More information is available from the National Association of Boards of Pharmacy®. If you experience an attempt at this type of scam, please email cforsaith@hda.org so that it can be shared with law enforcement.

ALERT Phishing Scam

The Board office has received reports that pharmacists are receiving calls that appear to come from the Board office’s main phone number and that the caller identifies himself or herself as an agent with the Board. The caller is able to confirm some of the pharmacist’s information, such as license number, National Provider Identifier number, and place of employment.

In some cases, the caller accuses the pharmacist of having committed a violation, that his or her license may be suspended or revoked, and that the pharmacist will be arrested if he or she does not answer the caller’s questions. In some cases, the caller alleges that the pharmacist was involved in prescription drug trafficking. Some pharmacists have reported that the caller becomes aggressive and demanding, threatening to have the Federal Bureau of Investigation come and arrest the pharmacist if he or she does not comply.

The Wyoming State Board of Pharmacy will not contact or interact with you in this manner.

The Federal Trade Commission has useful consumer information on how to recognize and avoid phishing scams available at https://www.consumer.ftc.gov/articles/how-recognize-and-avoid-phishing-scams. If you receive such a phone call, please call and report it to the Federal Communications Commission at 888/225- 5322.

DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists

The Drug Enforcement Administration (DEA) issued a critical alert to healthcare professionals, warning of recent scam calls targeting doctors and pharmacists. Fraudsters are impersonating DEA agents to steal sensitive information and possibly extort money.

DEA personnel will never contact medical practitioners or members of the public by telephone to request personal or sensitive information, demand money or any other form of payment. Legitimate DEA agents will only notify individuals of investigations or legal actions in person or via official letter.

Reported scam tactics continually change but often share many of the same characteristics. Callers use names found online of well-known DEA officials, retired or former Special Agents, and/or police officers in local departments. Callers will also provide fake badge numbers. Additionally, they may:

use an urgent and aggressive tone.
threaten arrest, prosecution, imprisonment, and, in the case of medical practitioners and pharmacists, revocation of their DEA registration.
reference National Provider Identifier numbers and/or state license numbers when calling a medical practitioner. They also may claim that patients are making accusations against the practitioner.
ask for personal information, such as social security number or date of birth.

Protecting Against Identity Theft

The best deterrence against these bad actors is awareness and caution. Anyone receiving a call from a person claiming to be with DEA should report the incident to the FBI at www.ic3.gov. The Federal Trade Commission provides recovery steps, shares information with more than 3,000 law enforcement agencies and takes reports at reportfraud.ftc.gov.

Reporting these scam calls will help federal authorities find, arrest, and stop the criminals engaged in this fraud. Impersonating a federal agent is a violation of federal law, punishable by up to three years in prison; aggravated identity theft carries a mandatory minimum sentence of two years in prison plus fines and restitution.

The DEA is committed to protecting healthcare professionals from these fraudulent schemes. By raising awareness and encouraging prompt reporting, we can help to stop these criminals and ensure the safety and security of our nation's healthcare workforce.

ALERT Fraudulent Prescription SCAM

The Board has received alerts from pharmacies that an individual or group of individuals are calling in prescriptions for Azithromycin, Ibuprofen, and Promethazine with Codeine. Most of the calls have allegedly come from practitioners in Washington. In some instances, they are asking for particular manufacturers of Promethazine with Codeine, attempting to call multiple sets of prescriptions in at one time, and have requested the pharmacy to ship into another state. The Board urges pharmacists to be cautious and to utilize their professional judgment when exercising their corresponding responsibility and to carefully evaluate such prescriptions for validity before dispensing.

Report abuse